Keyphrases
Heart Failure
100%
Racial Differences
100%
Spironolactone
100%
Potassium Concentration
100%
African American
83%
Serum Potassium
50%
Angiotensin-converting Enzyme Inhibitor (ACEi)
33%
Caucasian Patients
33%
Supplement Use
33%
Potassium Supplementation
33%
Patients with Heart Failure
33%
Potassium Supplements
33%
High Dose
16%
No Significant Difference
16%
Renal Function
16%
Medical Records
16%
High Prevalence
16%
Racial Groups
16%
Angiotensin Receptor Blockers
16%
Low Serum
16%
African American Patients
16%
Heart Failure Therapy
16%
Pharmacist
16%
Retrospective Medical Record Review
16%
Vasodilator Therapy
16%
Heart Failure Management
16%
Potassium Homeostasis
16%
Diuretic Therapy
16%
Medicine and Dentistry
Heart Failure
100%
Race Difference
100%
Spironolactone
100%
ACE Inhibitor
28%
Supplementation
28%
Medical Record
28%
Drug Megadose
14%
Prevalence
14%
Kidney Function
14%
Racial Group
14%
Vasodilator Agent
14%
Angiotensin Receptor Antagonist
14%
Potassium Homeostasis
14%
Diuretic Therapy
14%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
Isotopes of Potassium
100%
Spironolactone
100%
Dipeptidyl Carboxypeptidase Inhibitor
22%
Vasodilator Agent
11%
Prevalence
11%
Angiotensin Receptor Antagonist
11%
Diuretic Therapy
11%